The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Khismatullina Z.R.

Bashkir State Medical University, Russia

Koreshkova K.M.

Bashkir State Medical University, Russia

Predictors of psoriatic arthritis

Authors:

Khismatullina Z.R., Koreshkova K.M.

More about the authors

Journal: Russian Journal of Clinical Dermatology and Venereology. 2021;20(5): 7‑15

DOI: 10.17116/klinderma2021200517

Read: 5341 times

Download PDF (RU)
Contact the author
Table of contents

PREDICTORS OF PSORIATIC ARTHRITIS
PREDICTORS OF PSORIATIC ARTHRITIS

To cite this article:

Khismatullina ZR, Koreshkova KM. Predictors of psoriatic arthritis. Russian Journal of Clinical Dermatology and Venereology. 2021;20(5):7‑15. (In Russ.)
https://doi.org/10.17116/klinderma2021200517

Подписка 2026 Клиническая дерматология и венерология (Russian Journal of Clinical Dermatology and Venereology)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Analysis of medi­cal preventive stru­ctures staff resources in 2023. Russian Journal of Preventive Medi­cine. 2024;(10):45-51
Proton pump inhi­bitors: posi­tive and nega­tive properties. On the 45th anni­versary of their discovery. Russian Journal of Preventive Medi­cine. 2024;(11):135-140
Study of opinions of medi­cal students on medi­cal prevention issues. Russian Journal of Preventive Medi­cine. 2024;(12):69-74
Asse­ssment of risk of deve­loping fractures and sarcopenia and quality of life of patients with chro­nic kidney disease at the outpatient stage. Russian Journal of Preventive Medi­cine. 2024;(12):88-91
Gastric cancer: inci­dence, risk factors, screening. Russian Journal of Preventive Medi­cine. 2024;(12):135-139
The rela­tionship of diet and nutrition with the frequency of migraine atta­cks. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):30-35
Prevention of periodontal inflammation in microgravity mode­ling. Stomatology. 2024;(6-2):23-28
Effe­ctiveness of risk-guided cardiac mana­gement in patients with HER2-positive breast cancer and cancer therapy-related cardiac dysfunction. Russian Cardiology Bulletin. 2024;(4-2):144-153
Obstructive sleep apnea syndrome as a predictor of atrial fibrillation. Russian Journal of Preventive Medi­cine. 2025;(1):109-114
Vita­min D role in oral cavity diseases. Stomatology. 2025;(1):81-86
Abstract:

Psoriatic arthritis is a chronic inflammatory disease of the joints, spine and enthesis from the group of spondyloarthritis. In 70–84% of cases the psoriasis precedes the psoriatic arthritis by an average of 10 years. Currently, it is considered that psoriatic arthritis is secondary to psoriasis of the skin and develops on average 4 years before skin rashes. However, the skin phenomena manifest earlier than arthritis in 15–20% of cases. Psoriatic arthritis belongs to the group of seronegative peripheral arthritis characterized by parallelism in skin lesions, special radiological manifestations; some of them allow to suspect the psoriatic origin of the disease in the early stages. Along with other seronegative arthritis, the psoriatic arthritis is characterized by multi-factors causes — complex of genetic, immunological, and environmental factors on the pathogenesis. An important feature of this pathology is its manifestation before involvement of all periarticular structures, tendon-ligamentous apparatus that causes difficulties in diagnosis and timely treatment of patients. The article provides a review of the literature on predictors of psoriatic arthritis — factors that allow to anticipate the development and, in some cases, the course of this pathology.

Keywords:

arthritis
PASI index
CASPAR
psoriatic onychodystrophy
radiological data
inflammation of the periarticular structures
prevention

Authors:

Khismatullina Z.R.

Bashkir State Medical University, Russia

Koreshkova K.M.

Bashkir State Medical University, Russia

Received:

19.06.2020

Accepted:

09.07.2021

Close metadata

References:

  1. Badokin VV, Troshkina IA. Clinical heterogeneity of early psoriatic arthritis. Modern rheumatology. 2016;10(4):51-56. (In Russ.). https://doi.org/10.14412/1996-7012-2016-4-51-56
  2. Badokin VV. Clinical rheumatology. Selected Lectures. Ed. LitTerra. Ed. Bunchuk N.V. M. 2014;86-99. (In Russ.).
  3. Smolnikova MV, Smirnova SV. Genetic factors in the immunopathogenesis of psoriasis and psoriatic arthritis. Medical Immunology. 2014;16(3):211-220. (In Russ.). https://doi.org/10.15789/1563-0625-2014-3-211-220
  4. Kubanova AA. Dermatovenerology: Clinical recommendations. M.: DEKS-PRESS; 2010. (In Russ.).
  5. Korotaeva TV. Psoriatic arthritis: classification, clinical presentation, diagnosis, treatment. FSBI Research Institute of Rheumatology. VA Nasonova. Rheumatology Science and Practice. 2018;56(1):60-69. (In Russ.). https://doi.org/10.14412/1995-4484-2018-60-69
  6. Gladmann D, Gordon K, Ruderman E. Psoriasis and psoriatic arthritis. Berlin: Springer-Verlag; 2005;57-65.  https://doi.org/10.1007/3-540-27190-2_7
  7. Gubar EE, Loginova EYu, Korotaeva TV, Glukhova SI, Nasonov EL. Comparative characteristics of early psoriatic arthritis with and without lesion of the axial skeleton (subanalysis of the all-Russian register of patients with psoriatic arthritis). FSBI Research Institute of Rheumatology VA Nasonova. M. 2019. (In Russ.). https://doi.org/10.14412/1995-4484-2019-636-641
  8. Crowson CS, McEvoy MT, et al. Time Trends in Epidemiology and Characteristics of Psoriatic Arthritis Over 3 Decades: A Population-based Study. The Journal of Rheumatology. 2009;36(2):361-367.  https://doi.org/10.3899/jrheum.080691
  9. Amra A, Metin S, Kenan B, Sezgin S, Cengizhan A, Erkan D. & Ozgur K. The performance of classification criteria for juvenile spondyloarthropathies. Rheumatology International. 2017;37:2013-2018. https://doi.org/10.1007/s00296-017-3837-8
  10. Salvarani CA, Macchioni P, Olivieri I, Marchesoni A, Cutolo M, Ferraccioli G, Cantini F, Salaffi F, Padula A, Lovino C, Dovigo L, Bordin G, Davoli C, Pasero G, Alberighi OD. A comparison of cyclosporine, sulfasalazine, and symptomatic therapy in the treatment of psoriatic arthritis. J Rheumatol. 2001;28(10):2274-2282. https://www.jrheum.org/content/28/10/2274
  11. Parisi R, Symmons DP, Griffiths CE, Ashcroft DM. Identification and Management of Psoriasis and Associated ComorbidiTy (IMPACT) project team. Global epidemiology of psoriasis — a systematic review of incidence and prevalence. J Invest Dermatol. 2013;133(2):377.  https://doi.org/10.1038/jid.2012.339
  12. Azevedo V, Buiar P. Risk factors and predictors of psoriatic arthritis in patients with psoriasis. An Bras Dermatol. 2016;87(3):256-266.  https://doi.org/10.4172/2155-9554.1000357
  13. Veale DJ. Immunopathology of psoriasis and psoriatic arthriti. Veale D.J., Ritchlin C., FitzGerald O. Ann. Rheum. Dis. 2005;64(suppl II):16-34.  https://doi.org/10.1136/ard.2004.031740
  14. Asao K, Kanemaru H, Jinnin M. A case of psoriasis accompanied by arthritis after delivery. Biosci Trends. 2014;8(1):64-66.  https://doi.org/10.5582/bst.8.64
  15. Liu JT, Yeh HM, Liu SY, Chen KT. Psoriatic arthritis: Epidemiology, diagnosis, and treatment. World J Orthop. 2014;18;5(4):537-543.  https://doi.org/10.5312/wjo.v5.i4.537
  16. Dana AB, Jacopo S, Ilies R, Boca A. Sea buckthorn extract in the treatment of psoriasis. Experim and therapeutic med. 2018;17(2):1020-1023. https://doi.org/10.3892/etm.2018.6983
  17. Bartlett HS, Million RP. Targeting the IL-17-T(H)17 pathway. Nat Rev Drug Discov. 2015;14(1):11-12.  https://doi.org/10.1038/nrd4518
  18. Song IH, Hermann KG, Haibel H, Althoff CE, Poddubnyy D, Listing J, et al. Relationship between active inflammatory lesions in the spine and sacroiliac joints and new development of chronic lesions on whole-body MRI in early axial spondyloarthritis: results of the ESTHER trial at week 48 Ann Rheum Dis. 2011;70(7):1257-1263. https://doi.org/10.1136/ard.2010.147033
  19. Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med 2009;361(5): 496-509.  https://doi.org/10.1056/NEJMra0804595
  20. Noda S, Krueger JG, Guttman-Yassky E. The translational revolution and use ofbiologics in patients with inflammatory skin diseases. J Allergy Clin Immunol 2015;135(2):324-336.  https://doi.org/10.1016/j.jaci.2014.11.015
  21. Keijsers RR, Joosten I, van Erp PE, Koenen HJ, van de Kerkhof PC. Cellular sources of IL-17 in psoriasis: a paradigm shift? Exp Dermatol. 2014; 23(11):799-803.  https://doi.org/10.1111/exd.12487
  22. Chandran V, Raychaudhuri SP. Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis. J Autoimmun. 2010;34(3):314-321.  https://doi.org/10.1016/j.jaut.2009.12.001
  23. Griffiths C, Floranne CW, Barker J. Pathogenesis and clinical features of psoriasis. Lancet. 2007;370:263-271.  https://doi.org/10.1016/S0140-6736(07)61128-3
  24. Mease JP. Tumor necrosis factor in psoriatic arthritis: path physiology and treatment with TNF inhibitors. Ann Rheum Dis. 2012;61(4):298-304.  https://doi.org/10.1136/ard.61.4.298
  25. Augustin M, Holland B, Dartsch D, Langenbruch A, Radtke MA. Adherence in the treatment of psoriasis: a systematic review. Dermatology. 2011; 222(4):363-374.  https://doi.org/10.1159/000329026
  26. Eder L, Law T, Chandran V, Shanmugarajah S et al. Association between environmental factors and onset of psoriatic arthritis in patients with psoriasis. Arthritis Care Res. 2011;63:1011-1017. https://doi.org/10.1002/acr.20496
  27. Simon D, Faustini F, Englbrecht M, et al FRI0227 Analysis of Periarticular Bone Changes in Patients with Cutaneous Psoriasis without Associated Psoriatic Arthritis. Annals of the Rheumatic Diseases. 2014;73:464-465.  https://doi.org/10.1136/annrheumdis-2014-206347
  28. Goldenstein-Schainberg C, Favarato MH, Ranza R. Current and relevant concepts in psoriatic arthritis. Rev Bras Reumatol. 2012;52(1):98-106. PMID: 22286649.
  29. Lourdes NA, Felix SC. Psoriatic Arthritis Imaging. Drugs & Diseases. Radiology. Mar 11, 2019. https://emedicine.medscape.com/article/394752-print
  30. Zavadsky V. Psoriasis. Yaros. Medical State Academy. Yaroslavl. 2013;66:8-9. (In Russ.).
  31. Kampylafka, et al. Disease interception with interleukin-17 inhibition in high-risk psoriasis patients with subclinical joint inflammation — data from the prospective IVEPSA study Arthritis Research & Therapy. 2019;21:178.  https://doi.org/10.1186/s13075-019-1957-0
  32. Anwar Al Hammadi, MD, FRCPC; Chief Editor: Herbert S Diamond. What is the role of environmental factors in the etiology of psoriatic arthritis? J. Psoriatic Arthritis Q&A. 2019;1-3. 
  33. Chamurlieva MN. Optimization of clinical and instrumental diagnostic methods in the detection of early psoriatic arthritis in patients with psoriasis. M. 2015. (In Russ.).
  34. Molochkov VA, Badokin VV, Albanova VI. Psoriasis and psoriatic arthritis. Tovarishchestvo nauchnykh izdanii KMK. 2007. (In Russ.).
  35. Gladman DD. Psoriatic arthritis. Oxford textbook of rheumatology. Eds.: Maddison P.J. L.: Oxford University Press; 2018;1071-1084. https://doi.org/10.14412/1996-7012-2012-707
  36. Li W, Han J, Qureshi A. Smoking and risk of incident psoriatic arthritis in US women. Ann Rheum Dis. 2012;71(6):804-808.  https://doi.org/10.1136/annrheumdis-2011-200416
  37. Philip JM, Dafna DG. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). J Rheumatol. 2012;39(2):391-393.  https://doi.org/10.3899/jrheum.120818
  38. Saley YeA, Dyudyun AD, Polion NM, Noroha II. Psoriatic arthropathy. Dn. State Medical Academy, 2009. UDC 616.72-002.77-08-02. 
  39. Wilson FC, Icen M, Crowson CS, McEvoy M.T., Gabriel SE, Kremers HM. Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study. Arthritis Rheum. 2009;61:233-239.  https://doi.org/10.1002/art.24172
  40. Wrigth V, Moll JM. Psoriatic arthritis. Seminars in Arthritis and Rheumatism. Familial occurrence of psoriatic arthritis. Annals of the Rheumatic Diseases. American Journal of Medicine. 2015. https://doi.org/10.1136/ard.32.3.181
  41. Haroon M, Kirby B, FitzGerald O. High prevalence of psoriatic arthritis in patients with severe psoriasis with suboptimal performance of screening questionnaires. Ann Rheum Dis. 2013;72:736-740.  https://doi.org/10.1136/annrheumdis-2012-201706
  42. Li JH, Wang ZF, Xie YM, Zhao W. Clinical characteristics and combined use of medicine analysis of 2 991 hospitalized patients with psoriasis based on real world database. Zhongguo Zhong Yao Za Zhi. 2014;39(18):3442-3445.
  43. Scher JU, Ogdie A, Merola JF and Ritchlin C. Preventing psoriatic arthritis: focusing on patients with psoriasis at increased risk of transition. Nature Reviews/Reumatology. 2019;15:153.  https://doi.org/10.1038/s41584-019-0175-0
  44. Scher JU, Ogdie A, Merola JF, Ritchlin C. Preventing psoriatic arthritis: focusing on patients with psoriasis at increased risk of transition. Nat Rev Rheumatol. 2019;15(3):153-166.  https://doi.org/10.1038/s41584-019-0175-0
  45. Adebajo A, Boehncke WH, Gladman DD, Mease PJ. Psoriatic Arthritis and Psoriasis: Pathology and Clinical Aspects, Springer. 2016;45-52.  https://doi.org/10.1007/978-3-319-19530-8
  46. Sueiro FL, Juanola RX, Canete C, et al. Consensus statement of the Spanish Society of Rheumatology on the management of biologic therapies in psoriatic arthritis. Rheumatol Clin. 2011;7:179-188.  https://doi.org/10.1016/j.reuma.2011.02.001
  47. Ostergaard M, et al. The OMERACT psoriatic arthritis magnetic resonance imaging scoring system (PsAMRIS): definitions of key pathologies, suggested MRI sequences, and preliminary scoring system for PsA hands. J Rheumatol. 2009;36:1816-1824. https://doi.org/10.3899/jrheum.090352
  48. Rakkhit T, Wong B, Nelson TS, Hansen CB, Papenfuss JS, Panko J. Time to development of psoriatic arthritis decreases with smoking prior to psoriasis onset and increases with smoking after psoriasis onset. J Invest Dermatol. 2007;127:52. 
  49. Gottlieb AB, Kircik L, Eisen D, et al. Use of etanercept for psoriatic arthritis in the dermatology clinic: the Experience Diagnosing, Understanding Care, and Treatment with Etanercept (EDUCATE) study. J Dermatol Treat. 2006;17:343-352.  https://doi.org/10.1080/09546630600967166
  50. Soltani-Arabshahi R. Association between IL13 Polymorphisms and Psoriatic Arthritis University of Utah. Department of Dermatology 2009; 129(12):2777-2783. https://doi.org/10.1038/jid.2009.169
  51. Uluçkan Ö, et al. Chronic skin inflammation leads to bone loss by IL-17 — mediated inhibition of Wnt signaling in osteoblasts. Sci Transl Med. 2016;8: 330ra37. https://doi.org/10.1126/scitranslmed.aad8996
  52. Cao Qi, KM Mark, CS Lieber. Dilinoleoylphosphatidylcholine decreases acetaldehyde-induced TNF-a generation in Kupffer cells of ethanol-fed rats. Biochem and Biophysic Research Communications. 2012;299(3):450.  https://doi.org/10.1016/S0006-291X(02)02672-4
  53. Punzi L, Pianon M, Rossini P, et al. Clinical and laboratory manifestations of elderly onset psoriatic arthritis: a comparison with younger onset disease. Ann Rheum Dis. 1999;58:226-229.  https://doi.org/10.1136/ard.58.4.226
  54. Helliwell P, Porter G, Taylor W. Polyarticular psoriatic arthritis is more like oligoarticular psoriatic arthritis, than rheumatoid arthritis. Ann Rheum Dis. 2007;66:113-117.  https://doi.org/10.1136/ard.2006.054288
  55. Zisman D, Eder L, Elias M, et al. Clinical and demographic characteristics of patients with psoriatic arthritis in northern Israel. Rheumatol Int. 2012;32: 595-600.  https://doi.org/10.1007/s00296-010-1673-1
  56. Troshkina IA, Badokin VV, Krasnenko SO. The importance of dactylitis in the diagnosis of early psoriatic arthritis. Actual problems of modern rheumatology. Vypusk XXVII. Pod red. akad. RAMN A.B. Zborovskogo. Volgograd. 2010 (In Russ.). https://doi.org/10.14412/1996-7012-2016-4-51-56
  57. Gladman D, Chandran V. Observational cohort studies: lessons learnt from the University of Toronto Psoriatic Arthritis Program. Rheumatology (Oxford). 2011;50:25-31.  https://doi.org/10.1093/rheumatology/keq262
  58. Michet C, Mason T, Mazlumzadeh M. Hip joint disease in psoriatic arthritis: risk factors and natural history. Ann Rheum Dis. 2005;64:1068-1070. https://doi.org/10.1136/ard.2004.022228
  59. Kane D, Greaney T, Bresnihan B et al. Ultrasonography in the diagnosis and management of psoriatic dactylitis. J Rheumatol. 1999;26:1746-1751. PMID: 10451072.
  60. Healy P, Helliwell P. Measuring clinical enthesitis in psoriatic arthritis: assessment of existing measures and development of an instrument specific to psoriatic arthritis. Arthr Rheum. 2008;59:686-691.  https://doi.org/10.1002/art.23568
  61. Mease PJ, Gladman DD. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis. J Rheumatol. 2012;39(2):391-393.  https://doi.org/10.3899/jrheum.111231
  62. Reich K, Krüger K, Mössner R, Augustin M. Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis. Br J Dermatol. 2009;160(5):1040-1047. https://doi.org/10.1111/j.1365-2133.2008.09023.x
  63. Qu L, Yang Q, Liu H, Yu Y, Tian H, et al. Investigation of 20 non-HLA (human leucocyte antigen) psoriasis susceptibility loci in Chinese patients with psoriatic arthritis and psoriasis vulgaris. Br J Dermatol. 2013;168(5):1060-1065. https://doi.org/10.1111/bjd.12142
  64. Tinazzi I, McGonagle D, Biasi D, Confente S, Caimmi C, Girolomoni G, et al.26.Preliminary evidence that subclinical enthesopathy may predict psoriatic arthritis inpatients with psoriasis. J Rheumatol. 2011;38:2691-2692. https://doi.org/10.3899/jrheum.110505
  65. Chamurlieva MN, Loginova EYu, Korotaeva TV, Batkaev EA. Osteoarticular injury in psoriatic patients according to the data of PEST questionnaire and rheumatological clinicoinstrumental examination. Rheumatology Science and Practice. 2014;52(6):636-642.  https://doi.org/10.14412/1995-4484-2014-636-642
  66. Louden BA, Pearce DJ, Lang W, et al. A Simplified Psoriasis Area Severity Index (SPASI) for rating psoriasis severity in clinic patients. Dermatol Online J. 2004;10(2):7. PMID: 15530297.
  67. McHugh NJ, Balachrishnan C, Jones SM. Progression of peripheral joint disease in psoriatic arthritis: a 5-yr prospective study. Rheumatology (Oxford). 2003;42(6):778-783.  https://doi.org/10.1093/rheumatology/keg217
  68. Mattei PL, Corey KC, Kimball AB. Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index. (DLQI): the correlation between disease severity and psychological burden in patients treated with biological therapies. J Eur Acad Dermatol Venereol. 2014;28(3):333-337.  https://doi.org/10.1111/jdv.12106
  69. Augustin M, Holland B, Dartsch D, Langenbruch A, Radtke MA. Adherence in the treatment of psoriasis: a systematic review. Dermatology. 2011; 222(4):363-374.  https://doi.org/10.1159/000329026
  70. Takeshita J, Gelfand JM, Li P, Pinto L, Yu X, Rao P, et al. Psoriasis in the US Medicare population: prevalence, treatment, and factors associated with biologic use. J Invest Dermatol. 2015;135(12):2955-2963. https://dx.doi.org/10.1038/jid.2015.296
  71. Kruglova LS, Lvov AN. Early diagnosis of psoriatic arthritis and possibility of its control. Literature review Central State Medical Academy of the Administrative Department of the President of Russia, Moscow Scientific and Practical Centre for Dermatovenereology and Cosmetology. M. 2019. https://doi.org/10.33667/2078-5631-2019-2-26(401)-44-48
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.